Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 12 studies | 72% ± 26% | |
| GABAergic neuron | 9 studies | 62% ± 28% | |
| interneuron | 6 studies | 62% ± 28% | |
| retina horizontal cell | 6 studies | 68% ± 25% | |
| neuron | 5 studies | 35% ± 17% | |
| endothelial cell | 4 studies | 36% ± 19% | |
| astrocyte | 4 studies | 38% ± 24% | |
| GABAergic interneuron | 3 studies | 67% ± 22% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 14 studies | 44% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 93% | 1264.74 | 2468 / 2642 | 45% | 2.41 | 319 / 705 |
| intestine | 60% | 206.38 | 577 / 966 | 1% | 0.01 | 4 / 527 |
| heart | 57% | 108.85 | 487 / 861 | 0% | 0 | 0 / 0 |
| skin | 26% | 101.95 | 475 / 1809 | 4% | 0.09 | 19 / 472 |
| prostate | 20% | 24.22 | 48 / 245 | 8% | 0.22 | 38 / 502 |
| bladder | 19% | 23.19 | 4 / 21 | 3% | 0.07 | 14 / 504 |
| adrenal gland | 1% | 1.16 | 2 / 258 | 17% | 1.20 | 38 / 230 |
| esophagus | 12% | 15.89 | 180 / 1445 | 1% | 0.01 | 1 / 183 |
| adipose | 9% | 9.19 | 107 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0.77 | 2 / 653 | 7% | 0.44 | 45 / 605 |
| breast | 7% | 7.15 | 33 / 459 | 1% | 0.01 | 6 / 1118 |
| muscle | 7% | 8.00 | 59 / 803 | 0% | 0 | 0 / 0 |
| lung | 2% | 1.49 | 9 / 578 | 3% | 0.06 | 38 / 1155 |
| kidney | 0% | 0 | 0 / 89 | 4% | 0.13 | 39 / 901 |
| uterus | 0% | 0 | 0 / 170 | 4% | 0.18 | 17 / 459 |
| stomach | 3% | 2.95 | 11 / 359 | 0% | 0.01 | 1 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
| ovary | 2% | 1.81 | 3 / 180 | 0% | 0.01 | 1 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 2% | 0.04 | 3 / 178 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
| blood vessel | 0% | 1.67 | 6 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051835 | Biological process | positive regulation of synapse structural plasticity |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0043197 | Cellular component | dendritic spine |
| GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FRMPD4 |
| Protein name | FERM and PDZ domain containing 4 FRMPD4 protein FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso) |
| Synonyms | KIAA0316 PDZD10 PDZK10 |
| Description | FUNCTION: Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate. . |
| Accessions | Q14CM0 A0A590UJI1 ENST00000672869.2 ENST00000675598.1 A0A5F9ZH12 A0A6Q8PH73 B7ZLE1 ENST00000672010.1 A0A5F9ZHT2 A0A1W2PQW0 ENST00000657176.2 ENST00000640291.2 ENST00000616992.2 A0A087WYX8 ENST00000380682.5 ENST00000656302.1 A0A590UJL7 |
